biote Corp. (BTMD) vs INmune Bio, Inc. (INMB)

A side-by-side comparison of biote Corp. and INmune Bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BTMD vs INMB

growth of $100 · dividends reinvested · last 5y
BTMD -88.9% (-35.5%/yr)INMB -83.7% (-30.4%/yr)INMB compounded faster over this window
050100150200Start $10020222023202420252026$11$16
BTMD INMB

BTMD vs INMB: by the numbers

  • •BTMD is the larger company ($52M vs $50M market cap).
  • •BTMD is profitable (3.19% net margin) while INMB runs a net loss (-91866.00%).

Metrics side by side

Valuation

MetricBTMDINMB
P/E ratio10.03N/A
P/S ratio0.28N/A
P/B ratioN/A2.47
EV / EBITDA9.09N/A
FCF yield38.14%N/A

Profitability

MetricBTMDINMB
Gross margin71.46%100.00%
Operating margin18.50%-61738.00%
Net margin3.19%-91866.00%
ROEN/A-90.44%
ROIC13.63%-96.37%

Growth (annualized)

MetricBTMDINMB
Revenue CAGR (5Y)10.52%N/A
EPS CAGR (5Y)-25.90%N/A
FCF CAGR (5Y)3.81%N/A
Total return CAGR (5Y)-35.12%-36.88%

Frequently asked

Is BTMD or INMB more profitable?
BTMD runs the higher net margin — BTMD at 3.19% versus INMB at -91866.00%.
How have BTMD and INMB total returns compared?
Over the past 5 years, BTMD delivered -35.12% and INMB delivered -36.88% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.